Gene-environment interactions for breast cancer risk among chinese women: A report from the shanghai breast cancer genetics study

American Journal of Epidemiology

Volumn 177, Issue 2, 2013, Pages 161-170

  Li, Haixin ^a   Beeghly Fadiel, Alicia ^b   Wen, Wanqing ^b   Lu, Wei ^c   Gao, Yu Tang ^d   Xiang, Yong Bing ^d   Cai, Qiuyin ^b   Long, Jirong ^b   Shi, Jiajun ^b   Chen, Kexin ^a   Zheng, Ying ^c   Shu, Xiao Ou ^b   Zheng, Wei ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Shanghai Municipal Center for Disease Control and Prevention   (China)

^d SHANGHAI CANCER INSTITUTE   (China)

Author keywords

breast cancer risk; effect measure modification; gene environment interaction; genetic variants; genome wide association study

Indexed keywords

BREASTFEEDING; CANCER; GENETIC VARIATION; GENOTYPE-ENVIRONMENT INTERACTION; HEALTH RISK; PARTICIPATORY APPROACH; SPATIOTEMPORAL ANALYSIS; WOMENS HEALTH;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST DISEASE; BREAST FEEDING; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HORMONE SUBSTITUTION; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUATION; PARITY; PHYSICAL ACTIVITY; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

CHINA; SHANGHAI;

EID: 84872244478     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws238     Document Type: Article

References (29)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78-85.
2. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis. 1996;17(11):2279-2284.
3. Baselga J, Norton L. Focus on breast cancer. Cancer Cell. 2002;1(4):319-322.
4. Colditz GA, Baer HJ, Tamini RM. Breast cancer. In: Schottenfeld D, Fraumeni Joseph F, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2011.
5. Zhang B, Beeghly-Fadiel A, Long J, et al. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol. 2011;12(5):477-488.
6. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447(7148):1087- 1093.
7. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39(7):870-874.
8. Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007; 39(7):865-869.
9. Gold B, Kirchhoff T, Stefanov S, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA. 2008; 105(11):4340-4345.
10. Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40(6): 703-706.
11. Ahmed S, Thomas G, Ghoussaini M, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet. 2009;41(5):585-590.
12. Zheng W, Long J, Gao YT, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41(3):324-328.
13. Thomas G, Jacobs KB, Kraft P, et al. A multistage genomewide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41(5):579-584.
14. Long J, Cai Q, Shu XO, et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet. 2010; 6:pe1001002. (doi:10.1371/journal.pgen.1001002).
15. Turnbull C, Ahmed S, Morrison J, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504-507.
16. Travis RC, Reeves GK, Green J, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet. 2010; 375(9732):2143-2151.
17. Milne R, Gaudet M, Spurdle A, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium: a combined case-control study. Breast Cancer Res. 2010;12:pR110. (doi:10.1186/bcr2797).
18. Campa D, Kaaks R, Le Marchand L, et al. Interactions between genetic variants and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. J Natl Cancer Inst. 2011;103(16):1252-1263.
19. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000;87(2): 295-300.
20. Zheng W, Wen W, Gao YT, et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010; 102(13):972-981.
21. Li Y, Willer CJ, Ding J, et al. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34(8):816-834.
22. Long J, Shu XO, Cai Q, et al. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2357-2365.
23. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet. 2010;11(4):259-272.
24. Murcray CE, Lewinger JP, Gauderman WJ. Geneenvironment interaction in genome-wide association studies. Am J Epidemiol. 2009;169(2):219-226.
25. Huang Y, Ballinger D, Dai J, et al. Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Med. 2011;3(6):p42. (doi:10.1186/gm258).
26. Rebbeck TR, DeMichele A, Tran TV, et al. Hormonedependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of postmenopausal African-American and European-American women. Carcinogenesis. 2009;30(2):269-274.
27. Kawase T, Matsuo K, Suzuki T, et al. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. Int J Cancer. 2009;125(8):1946-1952.
28. Xu WH, Shu XO, Long J, et al. Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women. Am J Epidemiol. 2011;173(8):923-931.
29. Liang J, Chen P, Hu Z, et al. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis. 2008; 29(12):2341-2346.